Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $101.55M.
ENTERPRISE VALUE (EV)
$101.55M
Anixa Biosciences, Inc.
Market Cap
$102.75M
Enterprise Value (EV)
$101.55M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Anixa Biosciences, Inc. (ANIX) | $102.75M | $101.55M |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $103.14M | $100.92M |
| The Joint Corp. (JYNT)vs › | $101.36M | $81.24M |
| Definitive Healthcare Corp. (DH)vs › | $104.26M | $100.45M |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.68M | $93.13M |
| OnKure Therapeutics, Inc. (OKUR)vs › | $99.62M | N/A |
| Immunic, Inc. (IMUX)vs › | $106.52M | N/A |
| Vivani Medical, Inc. (VANI)vs › | $106.93M | $104.89M |
| Outlook Therapeutics, Inc. (OTLK)vs › | $106.96M | $114.15M |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.98M | $107.83M |
Market Cap
$102.75M
Total Debt
$41000.00
Cash
$1.24M
Enterprise Value
$101.55M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
